Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Factorial Diagnostics logo — Advancing high resolution, multi-omic cancer diagnostic assa...

Factorial Diagnostics

Advancing high resolution, multi-omic cancer diagnostic assays through innovative NGS library prep methods and bioinformatics algorithms for commercialization.

2-10 employees Venture round Biotechnology, Health Care

General Information

Company Name Factorial Diagnostics
Employees 2-10
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Factorial Diagnostics. To contact Factorial Diagnostics, visit factorialdx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Factorial Diagnostics compare?

A PDF of Factorial Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Factorial Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Factorial Diagnostics

Factorial Diagnostics, advancing high resolution, multi-omic cancer diagnostic assays through innovative NGS library prep methods and bioinformatics algorithms for commercialization, received its Venture Round investment from MBC Biolabs on 10 December 2020. The company, operating in the Biotechnology and Health Care industries, is focused on leveraging its novel NGS library prep methods and bioinformatics algorithms to commercialize high resolution, multi-omic, cancer diagnostic assays. With a powerful slogan emphasizing its commitment to technological advancement and a clear description of its mission, Factorial Diagnostics presents a compelling case to potential investors. This innovative approach to cancer diagnostics, grounded in cutting-edge technology and bioinformatics, positions Factorial Diagnostics as an intriguing prospect for venture capital firms seeking to invest in the biotech and healthcare sectors.

Business keywords: NGS library prep, bioinformatics algorithms, cancer diagnostics, multi-omic assays, high resolution assays, commercialization, innovative methods, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
MBC Biolabs
MBC Biolabs
10 Dec 2020

Factorial Diagnostics Alternatives & Competitors

View All Alternatives
Factorial Diagnostics vs
3DMedcare
3DMedcare United States

We are dedicated to providing precision diagnosis solutions to any patient, anytime, anywhere.

Series D
113 employees
Biopharma, Biotechnology
Factorial Diagnostics vs
OncoDNA
OncoDNA Belgium

Genomic and theranostic company specializing in precision medicine for the treatment of cancer and g...

Series C
52 employees
Biotechnology, Health Care
Factorial Diagnostics vs
ACT Genomics
ACT Genomics Taiwan

Make Personalized Medicine Accessible To All.

Venture round
121 employees
Biotechnology, Health Care
View all alternatives

FAQ About Factorial Diagnostics

Advancing high resolution, multi-omic cancer diagnostic assays through innovative NGS library prep methods and bioinformatics algorithms for commercialization.
Factorial Diagnostics operates in Biotechnology and Health Care. Its work centres on NGS library prep, bioinformatics algorithms, cancer diagnostics and multi-omic assays.
Factorial Diagnostics has approximately 2-10 employees.
Factorial Diagnostics has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to Factorial Diagnostics include 3DMedcare, OncoDNA, ACT Genomics, GeneCast Biotechnology Co., Ltd., Personal Genome Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Factorial Diagnostics and 3DMedcare are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Factorial Diagnostics, https://bouncewatch.com/company/factorial-diagnostics, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes